RSH 3.45% 3.0¢ respiri limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6

  1. 26,925 Posts.
    lightbulb Created with Sketch. 1740
    Like I told you guys, diagnosing Asthma attack and severity is what will be useful and not screening for wheeze which doesn't mean you are having Asthma attack or even Asthma, guessing they will need years of R&D and will be finally tested against the spirometry.

    "The Company has continued to invest into the upgrading of the App to increase utility and patient engagement. Added to the App was the Asthma Control Test (ACT) which is a clinically proven tool used by physicians to determine asthma severity and control. Although there is much more data to be collected, the initial results are very pleasing"
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.